INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![Medable CLSE thumbnail]( "The Future Of Patient Experience: Lessons From GLP-1 Studies")
The Future Of Patient Experience: Lessons From GLP-1 StudiesImprove adherence, retention, and data quality in GLP-1 and cardiometabolic trials through connected digital tools, real-time symptom tracking, caregiver support, and AI-assisted review.
-
![Sikich Success For Life Sciences]( "Sikich Success For Life Sciences")
Sikich Success For Life SciencesExplore an innovative solution for early-stage Life Sciences Organizations featuring dimensional charts of accounts, program and project management, multi-subsidiary support, and mass securities.
-
![AI Won't Replace You But Clinical Teams Using It Might]( "Pairing AI With High-Quality Data Leads To Clinical Success")
Pairing AI With High-Quality Data Leads To Clinical SuccessWhile artificial intelligence (AI) is already impacting clinical trial planning, pairing AI with trusted data makes it even more powerful. Experts reveal how AI is being used today across feasibility, site selection, and trial strategy.
-
![Solution-GettyImages-1060711170]( "10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves Them")
10 Roadblocks To Traditional Vendor Selection And How ClinAI Solves ThemVendor selection in clinical trials is a pivotal process. Explore ten widespread inefficiencies in the current approach and how you can resolve them.
-
Where Precision Drives Progress: Meeting The Rising Complexity Of Modern Clinical Trials8/20/2026
Discover how leading teams are using trusted data and targeted AI to design, plan, and execute clinical trials with the confidence today's science requires.
-
Your IRB, Simplified: Fast, Friendly, And Focused7/21/2026
IRB approval does not have to be defined by delays or confusion. Learn how expert guidance, regulatory support, and modern technology can help research teams move forward with greater efficiency.
-
Evaluating Wearable Data Platforms For Endpoint-Driven Studies2/24/2026
Endpoint‑driven studies need platforms that unify wearable data with trial systems, support derived measures, and ensure traceability so continuous data becomes reliable clinical evidence.
-
The State Of eSource Adoption In Clinical Trials5/12/2026
Learn how eSource-ready sites are improving trial efficiency, reducing site burden, and becoming essential to modern clinical trial execution.
-
The Silent Saboteurs: Why Rater Drift And Site Unpreparedness Cost CNS Trials More3/25/2026
High-end technology cannot fix poor rater preparation or complex patient needs. True data integrity requires bridging the gap between digital platforms and the reality of clinical implementation.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![GettyImages-1416816620 medical records, RWE]( "Generate Regulatory-Grade, RWE With Speed And Efficiency")
For teams managing real-world evidence or post-market studies, automation offers a scalable solution to streamline workflows, maintain compliance, and accelerate decision-making.
-
![GettyImages-1363583085 patient journal]( "Modern eConsent Built For Clinical Research Sites")
We partnered with leading academic medical centers, sponsors, hospital systems, and site networks to create an eConsent platform that is easy-to-use and minimizes risk.
-
![Data analytics iStock-1249408894]( "IQVIA Feasibility")
Employing a digital, data-first strategy, IQVIA Feasibility brings together survey data, confidential disclosure agreements (CDAs) and site intelligence data, enabling sponsors to efficiently collect vital information while improving the site experience.
-
![clinical-drug-development-GettyImages-1354172647]( "Drug Safety And Pharmacovigilance Services")
Navigating drug safety in the era of innovation-driven medicine
The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.
-
![GettyImages-1173740575 computer research data]( "Get Your Tile Into One Home")
For clinical trial technology vendors, it’s fast and easy to become part of the only industry-wide solution to sit tech overload.
